Mutation Count in ctDNA Predicts Patient Response to Immunotherapy – GenomeWeb
|
Mutation Count in ctDNA Predicts Patient Response to Immunotherapy
GenomeWeb NEW YORK (GenomeWeb) – New data this week has illustrated that a simple method of counting blood-borne DNA mutations in a panel of genes can distinguish patients who have a higher likelihood of responding to cancer immunotherapy. In the study … |
